Small sample.
Wider perspective.
Developing point-of-care tear biomarker technology to bring more objective measurement into focus.
Discover OcuCheck
Look closer.
Learn more.
Tear fluid carries measurable biomarkers. InnSight brings ophthalmology and engineering together to develop practical ways to investigate them.


From the laboratory. Toward the point of care.

Technology that
brings detail into view.
The platform is being developed around electrochemical sensing and proprietary coatings for quantitative tear biomarker analysis. Current company information discusses MMP-9 and tear film osmolarity.
Explore the technologyA clearer next step.

Explore the clinical perspective.
Understand the development aims and the company’s frequently asked questions.
Explore OcuCheckSee the team behind the technology.
Ophthalmologists, engineers and business specialists connect the research with practical development.
Meet InnSightStart a company conversation.
Continue to InnSight’s existing enquiry channels.
Get in touchLet’s look
a little closer.
Connect with the team about research, collaboration and development.
Start a conversation

